Adamis Pharmaceuticals Corp (NASDAQ:ADMP)

4.83
Delayed Data
As of Apr 24
 +0.07 / +1.47%
Today’s Change
2.62
Today|||52-Week Range
7.26
-21.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization14.6K0.000.00296.1K
 
 
 
 
Operating ExpensesGross Income-14.6K0.000.00-296.1K
 
 
 
General Expenses6.2M4.8M3.2M4.1M
 
 
 
 
 
Research And Development2.9M1.9M1.2M1.0M
 
 
 
 
 
Total Operating Expenses6.2M4.8M3.2M4.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.2M-4.8M-3.2M-4.4M
 
 
 
 
 
Extraordinary Credit0.00----4.9M
 
 
Extraordinary Charge0.00---1.5M--
 
 
Interest Expense On Debt744.3K35.4K2.3M8.6M
 
 
 
 
 
Other Expenses5.6K5.3K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.0M-4.8M-7.1M-8.2M
 
 
 
 
 
Discontinued Operations0.00-70.0K-130.0K0.00
 
 
 
Net Income-7.0M-4.9M-7.2M-8.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.8M5.3M5.9M7.3M
 
 
 
 
 
Shares To Calculate EPS Diluted3.8M5.3M5.9M7.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.87-$1.02-$1.19-$1.22
 
 
 
 
 
EPS Diluted-$1.87-$0.85-$1.19-$1.22
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account